Crossmark

Secukinumab: Zulassungsanpassung für 300 mg

Crossref DOI link: https://doi.org/10.1007/s15002-019-1777-2

Published Online: 2019-12-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

red,
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-01
More Information

Article History

First Online: 16 December 2019

Free to read: This content has been made available to all.